Policy Perspective
Control of Licensing Subgroup Presentation
The document outlines key themes discussed by the Control of Licensing Subgroup, focusing on the balance between control and communication in the context of licensing agreements. It distinguishes considerations before and after a license is granted. Pre-license factors include developing a licensing strategy, selecting an appropriate licensee, and conducting negotiations—all processes where mainta
NFRI Working Group Guiding Principles
The document outlines guiding principles to enhance collaborations between nonprofit funders and research institutions, emphasizing the importance of recognizing and respecting the distinct missions and objectives of each party. It advocates for the establishment of productive, long-term partnerships grounded in mutual trust, with the understanding that successful collaborations must align with an
Research Project Support Costs Work Group
The provided document appears to be largely composed of a mix of symbols and partially coherent text, which makes full interpretation challenging. However, it is possible to discern that the content is structured to address topics related to procedures, evaluations, and possibly instructions within an organizational or academic context. The document references steps or methods for carrying out act
Joint Association Letter on Industrial Hemp
COGR, the Association of American Universities, and the Association of Public and Land-grant Universities sent this letter to congressional leaders to advocate for the inclusion of Senate provisions in the final 2018 Farm Bill that would remove federal regulatory barriers to industrial hemp research. Specifically, they request explicit federal guidance allowing university researchers to obtain, gr
COGR Submits Letter to DEA Regarding Production Quotas for Schedule I & II Controlled Substances
COGR submitted formal comments to the U.S. Drug Enforcement Administration (DEA) regarding the proposed 2019 aggregate production quotas for Schedule I and II controlled substances, with particular attention to marijuana and its derivatives. COGR expressly supports the proposed increase in production quotas for marijuana and tetrahydrocannabinols, seeing this as a constructive move to advance scie
